SPD422 (Anagrelide hydrochloride)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SPD422 (Anagrelide hydrochloride), covering 2020-04-24 to 2020-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of SPD422 (Anagrelide Hydrochloride) in Healthy Adult Participants [Phase 1]